Detalhe da pesquisa
1.
Dense genome-wide SNP linkage scan in 301 hereditary prostate cancer families identifies multiple regions with suggestive evidence for linkage.
Hum Mol Genet
; 18(10): 1839-48, 2009 May 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-19251732
2.
Clinical grade production and characterization of a fusion protein comprised of the chemokine CCL2-ligand genetically fused to a mutated and truncated form of the Shiga A1 subunit.
Protein Expr Purif
; 66(2): 149-57, 2009 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-19264131
3.
Cy5.5-DTPA-galactosyl-dextran: a fluorescent probe for in vivo measurement of receptor biochemistry.
Nucl Med Biol
; 32(7): 687-93, 2005 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-16243643
4.
Germline missense variants in the BTNL2 gene are associated with prostate cancer susceptibility.
Cancer Epidemiol Biomarkers Prev
; 22(9): 1520-8, 2013 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-23833122
5.
Anti-inflammatory approaches that target the chemokine network.
Recent Pat Inflamm Allergy Drug Discov
; 5(1): 1-16, 2011 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-21184669
6.
Genome-wide linkage analyses of hereditary prostate cancer families with colon cancer provide further evidence for a susceptibility locus on 15q11-q14.
Eur J Hum Genet
; 18(10): 1141-7, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20407467